Evaluation of a genetically modified foot-and-mouth disease virus vaccine candidate generated by reverse genetics

BMC Veterinary Research

Volumn 8, Issue , 2012, Pages

  Li, Pinghua ^a   Bai, Xingwen ^a   Sun, Pu ^a   Li, Dong ^a   Lu, Zengjun ^a   Cao, Yimei ^a   Fu, Yuanfang ^a   Bao, Huifang ^a   Chen, Yingli ^a   Xie, Baoxia ^a   Liu, Zaixin ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; FOOT-AND-MOUTH DISEASE VIRUS; SUIDAE;

COMPLEMENTARY DNA; RECOMBINANT DNA; RECOMBINANT VACCINE; VIRUS ANTIGEN; VIRUS DNA; VIRUS PROTEIN; VIRUS VACCINE;

AMINO ACID SEQUENCE; ANIMAL; ANIMAL DISEASE; ARTICLE; CHINA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EPIDEMIC; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; GENETICS; IMMUNOLOGY; MOLECULAR CLONING; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; RANDOMIZED CONTROLLED TRIAL; REVERSE GENETICS; SWINE; SWINE DISEASE; TRANSGENIC ORGANISM; VIRUS GENOME; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, VIRAL; BASE SEQUENCE; CHINA; CLONING, MOLECULAR; DISEASE OUTBREAKS; DNA, COMPLEMENTARY; DNA, RECOMBINANT; DNA, VIRAL; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; GENOME, VIRAL; MOLECULAR SEQUENCE DATA; ORGANISMS, GENETICALLY MODIFIED; REVERSE GENETICS; SWINE; SWINE DISEASES; VACCINES, SYNTHETIC; VIRAL PROTEINS; VIRAL VACCINES; VIRUS REPLICATION;

EID: 84860992694     PISSN: None     EISSN: 17466148     Source Type: Journal    
DOI: 10.1186/1746-6148-8-57     Document Type: Article

References (51)

1. Bachrach HL. Foot and mouth disease virus. Annu Rev Microbiol 1968, 22:201-244. 10.1146/annurev.mi.22.100168.001221, 4301615.
2. Garland AJM. Vital elements for the successful control of foot-and-mouth disease by vaccination. Vaccine 1999, 17:1760-1766. 10.1016/S0264-410X(98)00443-5, 10194836.
3. Pereira HG. Subtyping foot-and-mouth disease virus. Dev Biol Stand 1977, 35:167-174.
4. Mateu MG, Da Silva JL, Rocha E, De Brum DL, Alonso A, Enjuanes L, Domingo E, Barahona H. Extensive antigenic heterogeneity of foot-and-mouth disease virus of serotype C. Virology 1988, 167:113-124. 10.1016/0042-6822(88)90060-8, 2460992.
5. Belsham GJ. Translation and replication of FMDV RNA. Curr Top Microbiol Immunol 2005, 288:43-70. 10.1007/3-540-27109-0_3, 15648174.
6. Kitson JDA, McCahon D, Belsham GJ. Sequence analysis of monoclonal antibody resistant mutants of type O foot-and mouth disease virus: evidence for the involvement of the three surface exposed capsid proteins in four antigenic sites. Virology 1990, 179:26-34. 10.1016/0042-6822(90)90269-W, 1699353.
7. Crowther JR, Farias S, Carpenter WC, Samuel AR. Identification of a fifth neutralizable site on type O foot-and-mouth disease virus following characterization of single and quintuple monoclonal antibody escape mutants. J Gen Virol 1993, 74:1547-1553. 10.1099/0022-1317-74-8-1547, 8393912.
8. Borrego B, Camarero JA, Mateu MG, Domingo E. A highly divergent antigenic site of foot-and-mouth disease virus retains its immunodominance. Viral Immunol 1995, 8:11-18. 10.1089/vim.1995.8.11, 8546800.
9. Mateu MG, Camarero JA, Giralt E, Andreu D, Domingo E. Direct evaluation of the immunodominance of a major antigenic site of foot-and-mouth disease virus in a natural host. Virology 1995, 206:298-306. 10.1016/S0042-6822(95)80045-X, 7831785.
10. Li ZY, Liu JX. The current state of vaccines used in the field for foot and mouth disease virus in China. Vaccine 2011, 10:13-15.
11. Lin YL, Jong MH, Huang CC, Shieh HK, Chang PC. Genetic and antigenic characterization of foot-and-mouth disease viruses isolated in Taiwan between 1998 and 2009. Vet Microbiol 2010, 145:34-40. 10.1016/j.vetmic.2010.03.003, 20362404.
12. Chen JD, Zhao MQ, Hui KH, Leung FC. Molecular Characterization of Foot-and-mouth Disease Virus in Hong Kong During 2001-2002. Virus genes 2006, 32:139-143. 10.1007/s11262-005-6869-1, 16604445.
13. Gleeson LJ. A review of the status of foot-and-mouth disease in South-East Asia and approaches to control and eradication. Rev Sci Tech Off Int Epiz 2002, 21:465-475.
14. Knowles NJ, Samuel AR. Molecular epidemiology of foot-and-mouth disease virus. Virus Res 2003, 91:65-80. 10.1016/S0168-1702(02)00260-5, 12527438.
15. Samuel AR, Knowles NJ. Foot-and-mouth disease type O viruses exhibit genetically and geographically distinct evolutionary lineages (topotypes). J Gen Virol 2001, 82:609-621.
16. Van Rensburg HG, Henry TM, Mason PW. Studies of genetically defined chimeras of a European type A virus and a South African Territories type 2 virus reveal growth determinants for foot-and-mouth disease virus. J Gen Virol 2004, 85:61-68. 10.1099/vir.0.19509-0, 14718620.
17. Wang Y, Liang YJ, Han J, Burkhart KM, Vaughn EM, Roof MB, Faaberg KS. Attenuation of porcine reproductive and respiratory syndrome virus strain MN184 using chimeric construction with vaccine sequence. Virology 2008, 371:418-429. 10.1016/j.virol.2007.09.032, 17976680.
18. Gillespie J, Juhan NM, Dicristina J, Key KF, Ramamoorthy S, Meng XJ. A genetically engineered chimeric vaccine against porcine circovirus type 2 (PCV2) is genetically stable in vitro and in vivo. Vaccine 2008, 26:4231-4236. 10.1016/j.vaccine.2008.05.051, 18579262.
19. Fowler VL, Knowles NJ, Paton DJ, Barnett PV. Marker vaccine potential of a foot-and-mouth disease virus with a partial VP1 G-H loop deletion. Vaccine 2010, 28:3428-3434. 10.1016/j.vaccine.2010.02.074, 20199761.
20. Hu S, Ma H, Wu Y, Liu W, Wang X, Liu Y, Liu X. A vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse genetics. Vaccine 2009, 27:904-910. 10.1016/j.vaccine.2008.11.091, 19095026.
21. Song JM, Lee YJ, Jeong OM, Kang HM, Kim HR, Kwon JH, Kim JH, Seong BL, Kim YJ. Generation and evaluation of reassortant influenza vaccines made by reverse genetics for H9N2 avian influenza in Korea. Vet Microbiol 2008, 130:268-276. 10.1016/j.vetmic.2008.02.005, 18374520.
22. Cao Y, Lu Z, Sun P, Fu Y, Tian F, Hao X, Bao H, Liu X, Liu Z. A pseudotype baculovirus expressing the capsid protein of foot-and-mouth disease virus and a T-Cell immunogen shows enhanced immunogenicity in mice. Virol J 2011, 8:77. 10.1186/1743-422X-8-77, 3050825, 21342530.
23. Feng Q, Chen X, Ma O, Liu Y, Ding M, Collins RA, Ko LS, Xing J, Lau LT, Yu AC, Chen J. Serotype and VP1 gene sequence of a foot-and-mouth disease virus from Hong Kong (2002). Biochem Biophys Res Commun 2003, 30:715-721.
24. Feng Q, Yu H, Liu Y, He C, Hu J, Sang H, Ding N, Ding M, Fung YW, Lau LT, Yu AC, Chen J. Genome comparison of a novel foot-and-mouth disease virus with other FMDV strains. Biochem Biophys Res Commun 2004, 323:254-263. 10.1016/j.bbrc.2004.08.086, 15351730.
25. Zhao MQ, Suo QL, Chen JD, Chen LJ, Xu YF. Sequence analysis of the protein-coding regions of foot-and-mouth disease virus O/HK/2001. Vet Microbiol 2008, 130:238-246. 10.1016/j.vetmic.2008.01.012, 18343054.
26. Buchholz UJ, Finke S, Conzelmann KK. Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J Virol 1999, 73:251-259. 103829, 9847328.
27. Rieder E, Bunch T, Brown F, Mason PW. Genetically engineered foot-and-mouth disease viruses with poly(C) tracts of two nucleotides are virulent in mice. J Virol 1993, 67:5139-5145. 237911, 8394441.
28. Paton DJ, King DP, Knowles NJ, Hammond J. Recent spread of foot-and-mouth disease in the Far East. Vet Rec 2010, 166:569-70.
29. Sambrook J, Fitsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual 1989, Cold Spring Harbor, Cold Spring Harbor Press.
30. Li P, Lu Z, Bao H, Li D, King DP, Sun P, Bai X, Cao W, Gubbins S, Chen Y, Xie B, Guo J, Yin H, Liu Z. In-vitro and in-vivo phenotype of type Asia 1 foot-and-mouth disease viruses utilizing two non-RGD receptor recognition sites. BMC Microbiol 2011, 11:154. 10.1186/1471-2180-11-154, 3224205, 21711567.
31. Rweyemamu MM, Hingley PJ. Foot-and-mouth disease virus strain differentiation: analysis of the serological data. J Biol Stand 1984, 12:191-194. 10.1016/S0092-1157(84)80053-0, 6203914.
32. Baxt BD, Morgan O, Robertson BH, Timpone CA. Epitopes on foot-and-mouth disease virus outer capsid protein VP1, involved in neutralization and cell attachment. J Virol 1984, 51:298-305. 254438, 6205165.
33. Rieder E, Baxt B, Lubroth J, Mason PW. Vaccines Prepared from Chimeras of Foot-and-Mouth Disease Virus (FMDV) Induce Neutralizing Antibodies and Protective Immunity to Multiple Serotypes of FMDV. J Virol 1994, 68:7092-7098. 237147, 7523697.
34. Samuel AR, Ouldridge EJ, Arrowsmith AE, Kitching RP, Knowles NJ. Antigenic analysis of serotype O foot-and-mouth disease virus isolates from the Middle East, 1981-1988. Vaccine 1990, 8:390-396. 10.1016/0264-410X(90)90100-Z, 2168609.
35. Tsai CP, Pan CH, Liu MY, Lin YL, Chen CM, Huang TS, Cheng IC, Jong MH, Yang PC. Molecular epidemiological studies on foot-and-mouth disease type O Taiwan viruses from the 1997 epidemic. Vet Microbiol 2000, 74:207-216. 10.1016/S0378-1135(00)00182-6, 10808089.
36. Yang PC, Chu RM, Chung WB, Sung HT. Epidemiological characteristics and financial costs of the 1997 foot-and-mouth disease epidemic in Taiwan. Vet Rec 1999, 145:731-734.
37. Liu W, Wei MT, Tong Y, Tang F, Zhang L, Fang L, Yang H, Cao WC. Seroprevalence and genetic characteristics of five subtypes of influenza A viruses in the Chinese pig population: A pooled data analysis. Vet J 2011, 187:200-206. 10.1016/j.tvjl.2009.10.026, 19945318.
38. Baxt B, Vakharia V, Moore DM, Franke AJ, Morgan DO. Analysis of neutralizing antigenic sites on the surface of type A12 foot-and-mouth disease virus. J Virol 1989, 63:2143-2151. 250631, 2467993.
39. Stave JW, Card JL, Morgan DO, Vakharia VN. Neutralization sites of type O1 foot-and-mouth disease virus defined by monoclonal antibodies and neutralization-escape variants. Virology 1988, 149:21-29.
40. Bittle JL, Houghten RA, Alexander H, Shinnick TM, Sutcliffe JG, Lerner RA, Rowlands DJ, Brown F. Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 1982, 298:30-33. 10.1038/298030a0, 7045684.
41. Di Marchi R, Brooke G, Gale C, Cracknell V, Doel T, Mowat N. Protection of cattle against foot-and-mouth disease by a synthetic peptide. Science 1986, 232:639-641. 10.1126/science.3008333, 3008333.
42. Grubman MJ, Baxt B. Foot-and-Mouth Disease. Clin Microbiol Rev 2004, 17:465-493. 10.1128/CMR.17.2.465-493.2004, 387408, 15084510.
43. Carrefio C, Roig X, Cairo J, Camarero J, Mateu MG, Domingo E, Giralt E, Andreu D. Studies on antigenic variability of C strains of foot-and-mouth disease virus by means of synthetic peptides and monoclonal antibodies. Int J Pept Protein Res 1992, 39:41-47.
44. Martinez MA, Hernandez J, Piccone ME, Palma EL, Domingo E, Knowles N, Mateu MG. Two mechanisms of antigenic diversification of foot-and-mouth disease virus. Virology 1991, 184:695-706. 10.1016/0042-6822(91)90439-I, 1653494.
45. Mateu MG, Martinez MA, Capucci L, Andreu D, Giralt E, Sobrino F, Brocchi E, Domingo E. A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C. J Gen Virol 1990, 71:629-637. 10.1099/0022-1317-71-3-629, 1690261.
46. McKenna TS, Lubroth J, Rieder E, Baxt B, Mason PW. Receptor binding site deleted foot-and-mouth disease (FMD) virus protects cattle from FMD. J Virol 1995, 69:5787-5790. 189442, 7637023.
47. Mateo R, Luna E, Rincon V, Mateu MG. Engineering viable foot-and-mouth disease viruses with increased thermostability as a step in the development of improved vaccines. J Virol 2008, 82:12232-12240. 10.1128/JVI.01553-08, 2593342, 18829763.
48. Sa-Carvalho D, Rieder E, Baxt B, Rodarte R, Tanuri A. Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle. J Virol 1997, 71:5115-5123. 191746, 9188578.
49. Botner A, Kakker NK, Barbezange C, Berryman S, Jackson T, Belsham GJ. Capsid proteins from field strains of foot-and mouth disease virus confer a pathogenic phenotype in cattle on an attenuated, cell-culture-adapted virus. J Gen Virol 2011, 92:1141-1151. 10.1099/vir.0.029710-0, 21270284.
50. Zhao Q, Pacheco J, Mason PW. Evaluation of genetically engineered derivatives of a Chinese strain of foot-and-mouth disease reveals a novel cell-binding site which functions in cell culture and in animals. J Virol 2003, 77:3269-3280. 10.1128/JVI.77.5.3269-3280.2003, 149744, 12584350.
51. Piatti P, Hassard S, Newman JFE, Brown F. Antigenic variants in a plaque-isolate of foot-and-mouth disease virus: implications for vaccine production. Vaccine 1995, 13:781-784. 10.1016/0264-410X(94)00057-T, 7483796.